Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: SUMATRIPTAN SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A203322
Product Number: 001
Approval Date: Apr 14, 2014
Applicant Holder Full Name: MYLAN LABORATORIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
